CORC  > 中国医学科学院 北京协和医学院
The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson's disease: A multicenter, double-blind, randomized, placebo-controlled study
Zhang, Zhenxin; Wang, Jian; Zhang, Xiaoying; Chen, Shengdi; Wang, Zhenfu; Zhang, Baorong; Liu, Chunfeng; Qu, Qiumin; Cheng, Yan; Li, Jie
2013
卷号19期号:11页码:1022-1026
关键词Parkinson's disease Ropinirole PR Chinese subjects
ISSN号1353-8020
DOI10.1016/j.parkreldis.2013.07.009
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6706319
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Zhang, Zhenxin,Wang, Jian,Zhang, Xiaoying,et al. The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson's disease: A multicenter, double-blind, randomized, placebo-controlled study[J],2013,19(11):1022-1026.
APA Zhang, Zhenxin.,Wang, Jian.,Zhang, Xiaoying.,Chen, Shengdi.,Wang, Zhenfu.,...&Zhu, Rongxuan.(2013).The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson's disease: A multicenter, double-blind, randomized, placebo-controlled study.,19(11),1022-1026.
MLA Zhang, Zhenxin,et al."The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson's disease: A multicenter, double-blind, randomized, placebo-controlled study".19.11(2013):1022-1026.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace